This study highlights the role of the NRG1/ERbB4 and PI3K/AKT/mTOR signaling pathways in the neuroprotective effects of aripiprazole and sertindole on ketamine-induced schizophrenia in rats. This evidence concerns the gene ERBB4 and schizophrenia.